This page tells you about recent information added to our patient information pages. There is information about
In October 2009 we relaunched our patient information website. Following testing with site users we reorganised all our information so that you can find it easily. We did this because the amount of content we had grew by at least 4 times since we redesigned in 2000. Since 2009 the amount of content on the site has grown even more. We are currently redesigning our website again and will soon have a great, fresh, new look.
We are currently refreshing the website and creating a new style for the content. Please help us by sending your feedback, telling us what you like and what you don't.
If there are any major developments, publications of guidance from the National Institute for Health and Care Excellence (NICE), or clinical guidelines, we amend the relevant sections on different types of cancer, and other relevant sections, at the time. As well as this ad hoc updating, our sections are reviewed and updated every 12 to 18 months.
In June 2016, we updated the
In May 2016, we updated the
- Coping with fatigue section
- Skin problems
- Getting NHS treatment
- Cancer and blood calcium levels
- Vulval cancer section
In April 2016, we updated the
In March 2016, we updated the
In February 2016, we updated the
In December 2015, we updated the
In November 2015, we updated the
In September 2015, we updated the
We are making every effort to extend and maintain our clinical trials database. This work is ongoing and by the end of September 2016 we had 525 trials listed that are open to patients in the UK. We aim to provide as comprehensive a listing of UK clinical trials in cancer care as we can. We also provide information about trials that have now closed to recruitment, and we add plain English summaries of trial results when these are available.
We would welcome your feedback on the clinical trials database. Click on 'feedback' at the top of any page and send us your views.
In September 2016 the following trials were added to our clinical trials database
- A trial looking at surgery alone for people with rectal cancer (SAILOR)
- A trial looking at a new way of having radiotherapy to the brain (HIPPO)
- A trial looking at using azacitidine for people with chronic graft versus host disease (AZTEC)
- A trial looking at improving chemoradiotherapy for people with cancer of the food pipe (SCOPE 2)
- A trial looking at stereotactic ablative radiotherapy for non small cell lung cancer (SARON)
- A study looking at targeted radiotherapy as part of a stem cell transplant for amyloidosis (TRALA)
- A study looking at chemotherapy and APR-246 for women with ovarian cancer (EUTROC-PiSARRO)
- A study to increase the reliability and accuracy of MRI scanning in cancer (QuIBs)
- A trial of enzalutamide for prostate cancer that has a high risk of comng back (ENZARAD)
- A study looking at chronic stress and fertility in women who had treatment for a childhood cancer (CSRF)
- A trial looking at ABT-414 with radiotherapy and temozolomide for glioblastoma (Intellance 1)
- A study of DTP3 for advanced myeloma
- A trial using stereotactic radiotherapy to treat prostate cancer (SPORT)
- A trial using a drug with hormone therapy to stop prostate cancer from spreading (SPECTRE)
- A trial of atezolizumab for bladder cancer after surgery (W029636)
- A study of alpelisib and fulvestrant for breast cancer that has come back or continued to grow despite hormone therapy (SOLAR-1)
- A study looking at nivolumab with temozolomide and radiotherapy for people with a glioblastoma (CA209548)
- A study to find why cancer treatment stops working (MAGENTA)
- A study looking at tamoxifen for people with myeloproliferative disorders (TAMARIN)
- A study looking at developing a new test to see how well chemotherapy is working in women with breast cancer (Neo-DDRD)
- A trial looking at trabectedin and pegylated liposomal doxorubicin for ovarian cancer (INOVATYON)
We also added results to the following trials
- A study looking at emergency hospital admissions for people with lung cancer and other lung conditions (EURECA)
- A trial looking at dabrafenib, trametinib and vemurafenib for melanoma
- A trial looking at carboplatin, gemcitabine and vandetanib for advanced transitional cell cancer that has spread (TOUCAN)
- A trial to find the best way to give radiotherapy for people with small cell lung cancer (CONVERT)
- A trial looking at zoledronic acid for cancer of the lung lining
We are able to answer your questions about cancer. You can ring Cancer Research UK's team of experienced cancer information nurses on freephone 0808 800 4040. Or you can send them a question about cancer by using our question form. Please note, we can't answer enquiries from overseas.
You can send us your views about our website on our feedback form.
Remember to include your email address in these forms. We have set up our feedback forms so that you can contact us anonymously, but if you want a personal reply you must type in your email address.
Rated 5 out of 5 based on 2 votes
Question about cancer? Contact our information nurse team